Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study
暂无分享,去创建一个
E. Rajakumara | D. Bhagwat | P. Choudhari | S. Mali | H. More | Rakesh P. Dhavale | Yasinalli Tamboli | Sanket Rathod | P. Sankpal | Sreenath Dey | Deepak Mahuli | Swaranjali Pawar
[1] P. Choudhari,et al. Exploration of limonoids for their broad spectrum antiviral potential via DFT, molecular docking and molecular dynamics simulation approach. , 2023, Natural product research.
[2] Pralhad K. Mudalkar,et al. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach , 2023, Journal of Molecular Modeling.
[3] C. Supuran,et al. Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids , 2023, ACS omega.
[4] P. Choudhari,et al. Exploration of bioactive molecules from Tinospora cordifolia and Actinidia deliciosa as an immunity modulator via molecular docking and molecular dynamics simulation study. , 2023, Natural product research.
[5] A. Al‐Sehemi,et al. Computational Exploration of Anti-cancer Potential of Flavonoids against Cyclin-Dependent Kinase 8: An In Silico Molecular Docking and Dynamic Approach , 2022, ACS omega.
[6] R. Gaikwad,et al. In-silico Study of Phytoconstituents from Tribulus terrestris as potential Anti-psoriatic agent , 2022, Asian Journal of Pharmaceutical Research.
[7] Rawaf Alenazy. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli , 2022, Biology.
[8] Janaína Esmeraldo Rocha,et al. Antibacterial and antibiotic modifying activity of chalcone (2E)-1-(4'-aminophenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps: In vitro and in silico approaches. , 2022, Microbial pathogenesis.
[9] Ibrahim M. Ibrahim,et al. Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects , 2022, Molecules.
[10] C. H. D. da Silva,et al. Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents , 2022, Frontiers in Molecular Biosciences.
[11] A. Al‐Sehemi,et al. In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2 , 2022, Journal of Saudi Chemical Society.
[12] K. Ilango,et al. Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme , 2022, Life.
[13] J. Rocha,et al. In vitro and in silico studies of chalcones derived from natural acetophenone inhibitors of NorA and MepA multidrug efflux pumps in Staphylococcus aureus. , 2021, Microbial pathogenesis.
[14] M. Abdalla,et al. Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties , 2021, Computers in Biology and Medicine.
[15] Tingjun Hou,et al. The impact of cross-docked poses on performance of machine learning classifier for protein–ligand binding pose prediction , 2021, Journal of Cheminformatics.
[16] L. Nahar,et al. Chalcones: Synthetic Chemistry Follows Where Nature Leads , 2021, Biomolecules.
[17] Bo Zheng,et al. Combating antibiotic resistance: current strategies for the discovery of novel antibacterial materials based on macrocycle supramolecular chemistry , 2021, Giant.
[18] A. Al‐Sehemi,et al. Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 Mpro , 2021, Journal of biomolecular structure & dynamics.
[19] S. Mouneir,et al. Synthesis, DFT calculation, pharmacological evaluation, and catalytic application in the synthesis of diverse pyrano[2,3-c]pyrazole derivatives. , 2021, Bioorganic chemistry.
[20] Diogo Santos-Martins,et al. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..
[21] Yang Ouyang,et al. Chalcone Derivatives: Role in Anticancer Therapy , 2021, Biomolecules.
[22] J. Rocha,et al. Antibacterial and antibiotic modifying activity, ADMET study and molecular docking of synthetic chalcone (E)-1-(2-hydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] F. Baquero,et al. Antibiotic resistance: Time of synthesis in a post-genomic age , 2021, Computational and structural biotechnology journal.
[24] J. S. Rana,et al. Antibiotic resistance in agriculture: Perspectives on upcoming strategies to overcome upsurge in resistance , 2021, Current research in microbial sciences.
[25] P. Rekha,et al. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India , 2021, Scientific Reports.
[26] J. Rocha,et al. Structural characterization, DFT calculations, ADMET studies, antibiotic potentiating activity, evaluation of efflux pump inhibition and molecular docking of chalcone (E)-1-(2-hydroxy-3,4,6-trimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one , 2021, Journal of Molecular Structure.
[27] R. Forgione,et al. Understanding the Antibacterial Resistance: Computational Explorations in Bacterial Membranes , 2021, ACS omega.
[28] R. Kasimanickam,et al. Antibiotics Use in Food Animal Production: Escalation of Antimicrobial Resistance: Where Are We Now in Combating AMR? , 2021, Medical sciences.
[29] Tugba G. Kucukkal,et al. Computational Chemistry Activities with Avogadro and ORCA , 2021 .
[30] B. Salehi,et al. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.
[31] P. Singh,et al. Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols? , 2020, Expert opinion on drug metabolism & toxicology.
[32] P. Higgins,et al. Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump , 2020, PloS one.
[33] P. Matczak,et al. A DFT study on the mechanism of the formation of 1,4,2,3‐dithiadiazinanes by head‐to‐head [3 + 3] cyclodimerization of thiocarbonyl S ‐imides , 2020 .
[34] Andy M. Lau,et al. Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB , 2020, Nature Communications.
[35] Shivanika C,et al. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease , 2020, Journal of biomolecular structure & dynamics.
[36] J. Rocha,et al. Potentiation of antibiotic activity by chalcone (E)-1-(4'-aminophenyl)-3-(furan-2-yl)-prop-2-en-1-one against gram-positive and gram-negative MDR strains. , 2020, Microbial pathogenesis.
[37] A. Al‐Sehemi,et al. Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis , 2020, Journal of biomolecular structure & dynamics.
[38] M. A. Alam,et al. DFT studies on vibrational and electronic spectra, HOMO–LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2,4,5-trimethoxyphenylmethylene)hydrazinecarbodithioate , 2020, Journal of Molecular Structure.
[39] Eric R. Geertsma,et al. AcrB: a mean, keen, drug efflux machine , 2020, Annals of the New York Academy of Sciences.
[40] P. K. Patial,et al. Phytochemical profile, antioxidant potential and DFT study of Araucaria columnaris (G. Forst.) Hook. Branch extracts , 2019, Natural product research.
[41] M. Diederich,et al. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology. , 2019, European journal of medicinal chemistry.
[42] B. Wilkinson,et al. Antibiotics: past, present and future. , 2019, Current opinion in microbiology.
[43] T. M. Belete. Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents , 2019, Human Microbiome Journal.
[44] Y. Lim,et al. Resveratrol controls Escherichia coli growth by inhibiting the AcrAB‐TolC efflux pump , 2019, FEMS microbiology letters.
[45] Yanfei Gao,et al. Enhanced strength–ductility synergy in ultrafine-grained eutectic high-entropy alloys by inheriting microstructural lamellae , 2019, Nature Communications.
[46] R. Lamuela-Raventós,et al. In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice. , 2019, Journal of natural products.
[47] Sakshi Singh,et al. Identification of small molecule activators for ErbB 4 receptor to enhance oligodendrocyte regeneration by in silico approach , 2018, Computational Toxicology.
[48] T. Kausar,et al. Identification of small molecule inhibitors of ALK2: a virtual screening, density functional theory, and molecular dynamics simulations study , 2018, Journal of Molecular Modeling.
[49] W. Reygaert. An overview of the antimicrobial resistance mechanisms of bacteria , 2018, AIMS microbiology.
[50] David Ramírez,et al. Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? , 2018, Molecules.
[51] V. Saini,et al. Design, synthesis, DFT, docking studies and ADME prediction of some new coumarinyl linked pyrazolylthiazoles: Potential standalone or adjuvant antimicrobial agents , 2018, PloS one.
[52] I. Nambi,et al. Antibiotic usage, residues and resistance genes from food animals to human and environment: An Indian scenario , 2018 .
[53] D. Chatterji,et al. Antibiotic Resistance: Current Perspectives , 2017, ACS omega.
[54] G. Bloom,et al. Antimicrobial resistance and universal health coverage , 2017, BMJ Global Health.
[55] S. Chakraborty,et al. Accelerated Healing of Diabetic Wounds Treated with L-Glutamic acid Loaded Hydrogels Through Enhanced Collagen Deposition and Angiogenesis: An In Vivo Study , 2017, Scientific Reports.
[56] Eugene N. Muratov,et al. Chalcone Derivatives: Promising Starting Points for Drug Design , 2017, Molecules.
[57] R. Melander,et al. The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach? , 2017, ACS infectious diseases.
[58] C. Xing,et al. Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.
[59] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[60] Lina Ding,et al. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. , 2016, Journal of ethnopharmacology.
[61] R. Bonomo,et al. Overview: Global and Local Impact of Antibiotic Resistance. , 2016, Infectious disease clinics of North America.
[62] Ruth Huey,et al. Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.
[63] P. Perjési,et al. Naturally occurring chalcones and their biological activities , 2016, Phytochemistry Reviews.
[64] Vivek Asati,et al. Anti-cancer chalcones: Structural and molecular target perspectives. , 2015, European journal of medicinal chemistry.
[65] M. Martins,et al. The ins and outs of RND efflux pumps in Escherichia coli , 2015, Front. Microbiol..
[66] H. Venter,et al. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition , 2015, Front. Microbiol..
[67] Douglas E. V. Pires,et al. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.
[68] Yu-chian Chen. Beware of docking! , 2015, Trends in pharmacological sciences.
[69] A. Yan,et al. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. , 2014, Biochemical and biophysical research communications.
[70] C. Xing,et al. Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice , 2014, Chemical research in toxicology.
[71] Wah Chiu,et al. Structure of the AcrAB-TolC multidrug efflux pump , 2014, Nature.
[72] Hong Wan,et al. What ADME tests should be conducted for preclinical studies , 2013 .
[73] J. Bartlett,et al. Seven ways to preserve the miracle of antibiotics. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] Attilio V Vargiu,et al. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations , 2012, Proceedings of the National Academy of Sciences.
[75] K. Diederichs,et al. Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop , 2012, Proceedings of the National Academy of Sciences.
[76] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[77] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[78] M. Diederich,et al. Dietary chalcones with chemopreventive and chemotherapeutic potential , 2011, Genes & Nutrition.
[79] B. Bandgar,et al. Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents. , 2010, Bioorganic & medicinal chemistry.
[80] Ricardo L. Mancera,et al. Ligand-Protein Cross-Docking with Water Molecules , 2010, J. Chem. Inf. Model..
[81] Ruth Nussinov,et al. Novel Approach for Efficient Pharmacophore-Based Virtual Screening: Method and Applications , 2009, J. Chem. Inf. Model..
[82] K. M. Pos. Drug transport mechanism of the AcrB efflux pump. , 2009, Biochimica et biophysica acta.
[83] Ruth Nussinov,et al. PharmaGist: a webserver for ligand-based pharmacophore detection , 2008, Nucleic Acids Res..
[84] Ruth Nussinov,et al. Deterministic Pharmacophore Detection Via Multiple Flexible Alignment of Drug-Like Molecules , 2007, RECOMB.
[85] J. Sikorski,et al. Recent advances in therapeutic chalcones , 2004 .
[86] H. van de Waterbeemd,et al. ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.
[87] Satoshi Murakami,et al. Crystal structure of bacterial multidrug efflux transporter AcrB , 2002, Nature.
[88] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[89] R. Srivastava,et al. Identification of novel anti-cryptosporidial inhibitors through a combined approach of pharmacophore modeling, virtual screening, and molecular docking , 2021 .
[90] W. Witte,et al. Antibiotic resistance. , 2013, International journal of medical microbiology : IJMM.
[91] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[92] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[93] J. Molnár,et al. Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them , 2014, Front. Pharmacol..